Trade Summary

1 week ago, Novack David F, serving as Pres, COO at Dynavax Technologies Corp (DVAX), sold 30,000 shares at $15.49 per share, for a total transaction value of $464,700.00. Following this transaction, Novack David F now holds 63,344 shares of DVAX.

This sale represents a 32.00% decrease in Novack David F's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, December 24, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 29, 2025, 5 days after the trade was made.

Dynavax Technologies Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.